Chattem Chemicals is an API manufacturer based in United States. It holds 24 active US drug master files and one valid CEP across a filed portfolio of 19 molecules. Its most recent recorded inspection, by US FDA, closed on 8 December 2022 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Chattanooga, United States | 1000524733 |
| Molecule | Regulators | Docs |
|---|---|---|
| Dextroamphetamine | US FDA | 3 |
| Amphetamine | US FDA | 2 |
| Fentanyl | US FDA | 2 |
| Glycine | EDQM, US FDA | 2 |
| Methylphenidate | US FDA | 2 |
| Ammonium Lactate | US FDA | 1 |
| Benzphetamine | US FDA | 1 |
| Buprenorphine | US FDA | 1 |
| Butabarbital | US FDA | 1 |
| Butalbital | US FDA | 1 |
| Codeine | US FDA | 1 |
| Dihydrocodeine | US FDA | 1 |
| Hydrocodone | US FDA | 1 |
| Hydromorphone | US FDA | 1 |
| Hydroxyamphetamine | US FDA | 1 |
| Metamfetamine | US FDA | 1 |
| Methadone | US FDA | 1 |
| Oxycodone | US FDA | 1 |
| Sodium Oxybate | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Chattem Chemicals comes back tiered against every other supplier able to file there.
Start for free